For the P&T Operating Procedures, and our Quality Assessment Tool and evidence grading methods, please visit our Policies and Procedures page.

The policy on public comment during meetings can be read at this page.

The Oregon P & T Committee is comprised of a 11-member volunteer, advisory committee of physicians, pharmacists and consumer representatives. The committee, established in compliance with the Omnibus Budget Reconciliation Act of 1990 (OBRA '90), is responsible for performing drug use review and making drug policy recommendations for OMAP.

The goals of the committee are to:

  • Measure and assess the utilization, quality, medical appropriateness, and cost of prescribed medication through evaluation of claims data.
  • Develop policy recommendations in relation to DUR.
  • Maintain the Oregon Preferred Drug List.


P&T Committee Final Meeting Minutes and Recommendations

To view the final minutes from past meetings, please click here.
To view the Oregon Health Authority recommendations from past meetings, please click here.


Membership Information

If interested in serving on the P & T Committee in the future or providing public testimony at Committee meetings, contact: Roger Citron at 503-947-5220 or by email: roger.a.citron @

You may also elect to receive notifications by email of meeting schedules, document postings and newsletters by subscribing to the OSUPHARMDI list-serv.


Meeting Information

For specific meeting information, including upcoming dates and meeting materials, please click here.



Administrative Support

  • Roger Citron
    OSU College of Pharmacy